Intravitreal Rituximab for the Treatment of Ocular Lymphoma and Glaucoma

Acta Ophthalmologica - United States
doi 10.1111/aos.13972_271
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Wiley

Related search

Ocular Hypertension and Glaucoma After Intravitreal Injection of Triamcinolone Acetonide

Middle Black Sea Journal of Health Science
2018English

Maintenance Rituximab or Observation After Frontline Treatment With Bendamustine-Rituximab for Follicular Lymphoma

British Journal of Haematology
Hematology
2018English

Anterior Segment Changes Following Intravitreal Bevacizumab Injection for Treatment of Neovascular Glaucoma

Clinical Ophthalmology
Ophthalmology
2011English

Treatment of Ocular Hypertension and Glaucoma With Dopamine Antagonists

Ophthalmic Research
MedicineMolecular NeuroscienceOphthalmologySensory SystemsCellular
1984English

Intravitreal Injection of Tissue Plasminogen Activator as Treatment for an Occluded Pars Plana Glaucoma Tube

Clinical Ophthalmology
Ophthalmology
2008English

Preservative-Free Tafluprost 0.0015% in the Treatment of Patients With Glaucoma and Ocular Hypertension

Advances in Therapy
MedicinePharmacology
2011English

Treatment of Central Nervous System Lymphoma in Rats With Intraventricular Rituximab and Serum

International Journal of Hematology
Hematology
2010English

Ocular Toxicity of Intravitreal Melphalan for Retinoblastoma in Chinese Patients

BMC Ophthalmology
MedicineOphthalmology
2019English

Lgr4 in Ocular Development and Glaucoma

Journal of Ophthalmology
Ophthalmology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy